We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current QGEN market cap is 8.98B. The company's latest EPS is USD 0.3868 and P/E is 107.34.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 509.16M | 458.8M | 496.35M | 501.87M | 521.2M |
| Operating Income | 110.62M | 94.95M | -228.44M | 112.1M | 119.1M |
| Net Income | 97.66M | 80.67M | -183.46M | 98.06M | 88.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.87B | 2.25B | 2.14B | 1.97B | 1.98B |
| Operating Income | 383.92M | 635.68M | 533.32M | 417.23M | 97.71M |
| Net Income | 73.64M | 537.05M | 575.66M | 484.81M | 83.59M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.12B | 5.81B | 5.58B | 6.27B | 5.69B |
| Total Liabilities | 2.31B | 2.21B | 2.18B | 2.74B | 2.12B |
| Total Equity | 3.81B | 3.6B | 3.41B | 3.53B | 3.57B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.93B | 6.21B | 6.35B | 6.17B | 5.69B |
| Total Liabilities | 3.45B | 3.35B | 2.96B | 2.31B | 2.12B |
| Total Equity | 2.48B | 2.86B | 3.39B | 3.87B | 3.57B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 459.46M | 133.08M | 299.7M | 482.04M | 673.55M |
| Investing | -87.66M | 6.43M | -11.41M | -242.44M | -249.23M |
| Financing | -433.83M | -292.09M | -419.47M | 66.08M | -422.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 492.27M | 675.99M | 751.12M | 492.78M | 673.55M |
| Investing | -503.06M | -211.7M | -735.58M | -94.53M | -249.23M |
| Financing | -74.32M | -177.8M | -152.65M | -460.61M | -422.9M |
| Market Cap | 8.98B |
| Price to Earnings Ratio | 107.34 |
| Price to Sales Ratio | 4.54 |
| Price to Cash Ratio | 13.52 |
| Price to Book Ratio | 2.52 |
| Dividend Yield | - |
| Shares Outstanding | 216.12M |
| Average Volume (1 week) | 1.73M |
| Average Volume (1 Month) | 1.38M |
| 52 Week Change | -0.11% |
| 52 Week High | 49.2864 |
| 52 Week Low | 37.63 |
| Spread (Intraday) | 11.72 (23.44%) |
| Company Name | Qiagen NV |
| Address |
hulsterweg 82 venlo, limburg 5912-PL |
| Website | https://www.qiagen.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
